医学
氯吡格雷
经皮冠状动脉介入治疗
传统PCI
阿司匹林
心肌梗塞
人口
装载剂量
安慰剂
内科学
噻氯匹定
随机对照试验
心脏病学
外科
替代医学
病理
环境卫生
作者
Steven R. Steinhubl,Peter B. Berger,J. Tift Mann,Edward T.A. Fry,Augustin DeLago,Charles Wilmer,Eric J. Topol,for the CREDO Investigators
出处
期刊:JAMA
[American Medical Association]
日期:2002-11-20
卷期号:288 (19): 2411-2411
被引量:3103
标识
DOI:10.1001/jama.288.19.2411
摘要
SPIRIN IS A CORNERSTONE OF therapy for patients undergoing coronary intervention.Its use is considered a standard of care before the procedure and lifelong following revascularization.2][3][4] However, the optimal timing for the initiation of clopidogrel and aspirin, as well as their duration of treatment following a PCI procedure, remains unknown.][7] Despite the consistency of this observation, patient or procedural characteristics may have biased the results in
科研通智能强力驱动
Strongly Powered by AbleSci AI